UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9962, pp. 43 - 54
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Tissue Scaffolds | Young Adult | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Everolimus | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Treatment Outcome | Myocardial Ischemia - drug therapy | Absorbable Implants | Coronary Angiography | Adolescent | Quality of Life | Aged | Biocompatible Materials - therapeutic use | Myocardial Ischemia - surgery | Ischemia | Coronary heart disease | Stent (Surgery) | Heart attacks | Medical imaging | Coronary vessels | Cardiovascular disease | Physiology | Nitrates | Cardiology | Stents | Thrombosis | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9667, pp. 897 - 910
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Clinical Trials as Topic | Absorbable Implants | Drug-Eluting Stents - adverse effects | Multicenter Studies as Topic | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Everolimus | Coronary Restenosis - etiology | Usage | Patient outcomes | Endovascular stents | Studies | Heart attacks | Medical imaging | Stents | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 371, Issue 9616, pp. 899 - 907
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Prospective Studies | Humans | Middle Aged | Coronary Restenosis | Male | Absorbable Implants | Angioplasty, Balloon, Coronary | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Safety | Everolimus | Clinical trials | Heart attacks | Angioplasty | Stents | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 2015, Volume 8, Issue 13, pp. 1715 - 1726
Cardiovascular | maximal lumen diameter | major adverse cardiac event(s) | bioresorbable scaffold | major adverse cardiac event(s) | maximal lumen diameter | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Vessels - diagnostic imaging | Multivariate Analysis | Predictive Value of Tests | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Logistic Models | Male | Treatment Outcome | Coronary Artery Disease - mortality | Prosthesis Design | Absorbable Implants | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Time Factors | Female | Aged | Odds Ratio | Myocardial Infarction - etiology | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article
JACC. Cardiovascular imaging, ISSN 1936-878X, 2012, Volume 5, Issue 3, pp. S28 - S37
Cardiovascular | atherosclerosis | coronary plaque | disease progression | computed tomography coronary angiography | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Plaque, Atherosclerotic - diagnostic imaging | Predictive Value of Tests | United States - epidemiology | Prospective Studies | Humans | Middle Aged | Ultrasonography, Interventional | Vascular Calcification - diagnostic imaging | Male | Plaque, Atherosclerotic - epidemiology | Tomography, X-Ray Computed | Angioplasty, Balloon, Coronary - adverse effects | Coronary Angiography - methods | Time Factors | Adult | Female | Coronary Stenosis - epidemiology | Coronary Stenosis - diagnostic imaging | Severity of Illness Index | Reproducibility of Results | Coronary Stenosis - therapy | Europe - epidemiology | Treatment Outcome | Disease Progression | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Plaque, Atherosclerotic - therapy | Vascular Calcification - epidemiology | Coronary Artery Disease - epidemiology | Observer Variation | Index Medicus
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 2017, Volume 10, Issue 8, pp. 786 - 795
Cardiovascular | vasomotion | bioresorbable scaffold | ABSORB | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Vessels - diagnostic imaging | Coronary Vessels - physiopathology | Humans | Ultrasonography, Interventional | Vasomotor System - drug effects | Everolimus - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - physiopathology | Time Factors | Vasomotor System - physiopathology | Everolimus - adverse effects | Nitroglycerin - administration & dosage | Cardiovascular Agents - administration & dosage | Coronary Vessels - drug effects | Treatment Outcome | Coated Materials, Biocompatible | Vasoconstriction - drug effects | Absorbable Implants | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Vasodilation - drug effects | Cardiovascular Agents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Vasodilator Agents - administration & dosage | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2011, Volume 58, Issue 3, pp. 258 - 264
Cardiovascular | Internal Medicine | outcome | small vessels | bioresorbable everolimus-eluting vascular scaffold | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Coronary Vessels - diagnostic imaging | Coronary Vessels - pathology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Endosonography | Tomography, Optical Coherence | Humans | Middle Aged | Male | Treatment Outcome | Absorbable Implants | Tissue Scaffolds | Coronary Angiography | Female | Everolimus | Creatine | Creatine kinase | Cardiology | Angiogenesis inhibitors | Studies | Heart attacks | Coronary vessels | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 2011, Volume 4, Issue 9, pp. 992 - 1001
Cardiovascular | incomplete stent | strut apposition | uncovered struts | late acquired incomplete stent | optical coherence tomography | bioresorbable scaffolds | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Angioplasty, Balloon, Coronary - instrumentation | Tomography, Optical Coherence | United States | Europe | Humans | Middle Aged | Male | Treatment Outcome | Prosthesis Design | New Zealand | Angioplasty, Balloon, Coronary - adverse effects | Sirolimus - administration & dosage | Time Factors | Thrombosis - etiology | Biocompatible Materials | Female | Aged | Thrombosis - prevention & control | Australia | Everolimus | Thrombosis - diagnosis | Index Medicus
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 2014, Volume 7, Issue 5, pp. 482 - 493
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 2011, Volume 4, Issue 12, pp. 1271 - 1280
Cardiovascular | bioresorbable vascular scaffold | optical coherence tomography | stent/scaffold thrombosis | minimal lumen diameter | drug-eluting stent(s) | neointimal thickness | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Predictive Value of Tests | Coronary Stenosis - etiology | Angioplasty, Balloon, Coronary - instrumentation | Humans | Metals | Middle Aged | Male | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Coronary Stenosis - prevention & control | Time Factors | Female | Everolimus | Cardiovascular Agents - administration & dosage | Coronary Vessels - pathology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Tomography, Optical Coherence | Treatment Outcome | Chi-Square Distribution | Absorbable Implants | Coronary Angiography | Coronary Stenosis - pathology | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Tunica Intima - pathology | Coronary Artery Disease - diagnosis | Aged | Coronary Stenosis - diagnosis | Index Medicus
Journal Article